Clinical trial / 2014
In patients with type 2 diabetes and lipid abnormalities, green tea extract improved insulin resistance and glucagon-like peptide 1 only within the group.
Ninety-two patients with type 2 diabetes and lipid abnormalities were randomized to take 500 mg green tea extract or cellulose placebo three times daily for 16 weeks; 39 in the intervention arm and 38 controls completed the study. Within-group comparisons showed green tea extract significantly decreased triglycerides and HOMA-IR (from 5.4±3.9 to 3.5±2.0), increased HDL-C, and increased glucagon-like peptide 1. Adiponectin, apolipoprotein A1, and apolipoprotein B100 increased significantly in both arms. However, in between-group comparisons, only a decreasing trend in triglycerides was observed.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 92 subjects with type 2 diabetes mellitus and lipid abnormalities (77 completed)
- What was measured
- Glycemic and lipid profiles, anthropometrics, safety parameters, obesity-related hormone peptides
THE PAPER
Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.
Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. PLoS One, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.